Fear of Cancer Recurrence in Genitourinary Cancer

  • days left to enroll
  • participants needed
  • sponsor
    Ludwig-Maximilians - University of Munich
Updated on 26 January 2021


To perform an analysis of independent predictors of fear of cancer recurrence in patients with malignant genitourinary diseases and their impact on quality of life and survival

Condition Malignant neoplasm of prostate, Adenocarcinoma, Malignant neoplasm of kidney, Prostatic disorder, Transitional cell carcinoma, Renal Cell Carcinoma, Malignant neoplasm of testis, Prostate Disorders, Prostate Cancer, Early, Recurrent, Kidney Cancer, Prostate Cancer, Testicular Cancer, Malignant Adenoma, Renal Cell Cancer, Renal Cancer, Urothelial Carcinoma, Fear of Cancer Recurrence, prostate carcinoma, cancer, renal, prostate cancers, testis cancer
Treatment FCR7 questionnaire
Clinical Study IdentifierNCT04535921
SponsorLudwig-Maximilians - University of Munich
Last Modified on26 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Fear of Cancer Recurrence or Renal Cell Cancer or Kidney Cancer or Malignant neoplasm of testis or Testicular Cancer or Malignant neoplasm of kidney o...?
Do you have any of these conditions: Adenocarcinoma or Testicular Cancer or Urothelial Carcinoma or Prostate Cancer, Early, Recurrent or Prostatic disorder or cancer, renal or Malignant A...?
histologically confirmed diagnosis of either prostate, urothelial cell, testicular or renal cell cancer
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note